Hyaluronic Acid Does NOT Support True Cartilage Healing
The current evidence does not support hyaluronic acid (HA) as an agent that promotes true cartilage healing or regeneration, and the most recent high-quality guideline recommends against its routine use for knee osteoarthritis. 1
Guideline-Based Recommendation
The 2022 AAOS Clinical Practice Guideline explicitly states that intra-articular hyaluronic acid was not consistently supported by 17 high-quality and 11 moderate-quality studies 1. While the guideline acknowledges potential benefit in some patients (number needed to treat = 17), the evidence shows such inconsistency that the recommendation is against routine use of hyaluronic acid in patients with knee osteoarthritis 1.
Key Evidence Points:
- HA provides symptomatic relief, not structural healing: The mechanism is primarily viscosupplementation and temporary pain reduction, not cartilage regeneration
- Inconsistent clinical outcomes: The guideline could not identify which subset of patients benefit from HA, explaining the observed inconsistency 1
- Inferior to corticosteroids: Intra-articular corticosteroids had considerably more evidence (19 high-quality studies) supporting their use, though benefits lasted only ~3 months 1
Important Distinction: Symptom Management vs. Healing
The EULAR 2021 recommendations acknowledge HA as an available injectable for IAT but focus on procedural aspects rather than endorsing its regenerative capacity 2. This reflects the reality that HA may temporarily improve joint mechanics and reduce pain but does not regenerate damaged cartilage tissue.
Preclinical Research Context
While recent animal studies suggest potential chondroprotective effects 3, 4, 5, these findings have not translated to consistent clinical benefit in humans. The 2026 preclinical studies showing cartilage regeneration with modified HA formulations 6, 7, 8 remain experimental and are not yet validated in human trials.
Common Pitfall to Avoid:
Do not confuse symptomatic improvement with actual cartilage healing. Patients may report reduced pain after HA injection due to improved joint lubrication, but this does not indicate structural cartilage repair or disease modification.
Clinical Bottom Line:
For patients seeking cartilage healing or regeneration, HA injections should not be recommended as a disease-modifying treatment. If considering intra-articular therapy for symptomatic relief in knee OA, corticosteroid injections have stronger evidence 1. Weight loss, NSAIDs, and physical therapy remain the foundation of non-surgical OA management with proven benefits for pain and function 1.